SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001240015-04-000020
Filing Date
2004-10-27
Accepted
2004-10-27 17:27:05
Documents
2
Period of Report
2004-10-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3624
2 powerofattorney.htm EX-24 3070
  Complete submission text file 0001240015-04-000020.txt   8535
Mailing Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545
Business Address 25861 INDUSTRIAL BLVD HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Issuer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address
Business Address LYNX THERAPEUTICS INC 25861 INDUSTRIAL BLVD. HAYWARD CA 94545
KOZIN MARC D (Reporting) CIK: 0001241647 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22570 | Film No.: 041100333